Market Overview

From Earlier: UBS Downgrades Teva Pharmaceutical Industries Limited to Neutral

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for TEVA

DateFirmActionFromTo
Dec 2017GuggenheimInitiates Coverage OnNeutral
Nov 2017CitigroupMaintainsNeutral
Nov 2017JP MorganDowngradesNeutralUnderweight

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (TEVA)

Partner Center